K, J., AJ, W., & MA, B. (2024). Differential effects of cannabis constituents on schizophrenia-related psychosis: A rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen. Frontiers in psychiatry, 15, 1386263. https://doi.org/10.3389/fpsyt.2024.1386263
Chicago Style (17th ed.) CitationK, Johnson, Weldon AJ, and Burmeister MA. "Differential Effects of Cannabis Constituents on Schizophrenia-related Psychosis: A Rationale for Incorporating Cannabidiol into a Schizophrenia Therapeutic Regimen." Frontiers in Psychiatry 15 (2024): 1386263. https://doi.org/10.3389/fpsyt.2024.1386263.
MLA (9th ed.) CitationK, Johnson, et al. "Differential Effects of Cannabis Constituents on Schizophrenia-related Psychosis: A Rationale for Incorporating Cannabidiol into a Schizophrenia Therapeutic Regimen." Frontiers in Psychiatry, vol. 15, 2024, p. 1386263, https://doi.org/10.3389/fpsyt.2024.1386263.